DrugDashboards

Alcaftadine

Alcaftadine · ALCAFTADINE 2.5 mg/mL · Solution/ Drops · Ophthalmic · Aurohealth LLC

NDC 58602-0605-40 · 1 BOTTLE in 1 CARTON / 5 mL in 1 BOTTLE · ANDA · View full market →

The short version

4 companies supply this market — a reasonable cushion if one runs into trouble.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for alcaftadine (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA210659
TE code
Approval date
Jun 23, 2023
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Alcaftadine (Solution/ Drops)

LabelerStrengthFirst seenLast seen
Allergan, Inc.ALCAFTADINE 2.5 mg/mLJul 15, 2026Sep 3, 2026
Alembic Pharmaceuticals Inc.ALCAFTADINE 2.5 mg/mLJul 15, 2026Sep 2, 2026
Aurohealth LLCALCAFTADINE 2.5 mg/mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedALCAFTADINE 2.5 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Alcaftadine — NDC 58602-0605-40," retrieved September 3, 2026, https://drugdashboards.com/drug/58602060540.

Free to cite with attribution — see how the data is put together.